Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species

Objectives: There is debate on whether the use of third-generation cephalosporins (3GC) increases the risk of clinical failure in bloodstream infections (BSIs) caused by chromosomally-mediated AmpC-producing Enterobacterales (CAE). This study evaluates the impact of definitive 3GC therapy versus oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Derrick, Caroline, Bookstaver, P. Brandon, Lu, Zhiqiang K., Bland, Christopher M., King, S. Travis, Stover, Kayla R., Rumley, Kathey, MacVane, Shawn H., Swindler, Jenna, Kincaid, Scott, Branan, Trisha, Cluck, David, Britt, Benjamin, Pillinger, Kelly E., Jones, Bruce M., Fleming, Virginia, DiMondi, V. Paul, Estrada, Sandy, Crane, Brad, Odle, Brian, Al-Hasan, Majdi N., Justo, Julie Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277875/
https://www.ncbi.nlm.nih.gov/pubmed/32423104
http://dx.doi.org/10.3390/antibiotics9050254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277875/
https://www.ncbi.nlm.nih.gov/pubmed/32423104
http://dx.doi.org/10.3390/antibiotics9050254

Ejemplares similares